Capricor Therapeutics (NASDAQ:CAPR) filed to sell 2.8M shares of common stock for holders. This prospectus is not an offer to sell. Filing More on Capricor Therapeutics Capricor: DMD Treatment Focus ...

Crawford & Company® (NYSE: CRD-A and CRD-B) will issue its earnings release for its third quarter ended September 30, 2024, on Monday, November 4, 2024, at 4:15 p.m. Eastern Time. The conference call, ...

Americans are more likely to regret the things they didn’t do than the things they have done, a recent survey found.

Otis Worldwide Corporation's share price increased over 160% since its spin-off. Read more about OTIS stock here.

LMT's Q3 results were mixed, with net sales missing consensus but adjusted EPS beating it. The company also raised its FY24 ...

Inspire Veterinary Partners, Inc. (Nasdaq:IVP) (”Inspire” or the “Company”), an owner and provider of pet health care ...

Elliott Investment Management, which owns 10% of Southwest's common stock, has pushed for months to replace some board members, oust CEO Bob Jordan and review its strategy to improve financial ...

Three high-octane income stocks -- sporting yields of 10.4% to 12.8% -- are perfectly positioned to fatten the pocketbooks of ...

TSLY's strategy involves writing covered calls and credit call spreads on Tesla. Read why we believe it's prudent to wait ...

Firan Technology Group will acquire Flyht Aerospace Solutions. The Toronto aerospace and defense-electronics company on Monday said it will purchase all of Flyht's outstanding shares for a combination ...

BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological ...

As of September 30, Sandy Spring has amassed $14.4 billion in assets, $11.7 billion in total deposits and $11.5 billion in ...